Aug 21, 2026 04:13PM
Aug 14, 2026 08:05AM
Aug 13, 2026 04:06PM
Aug 13, 2026 04:05PM
Aug 12, 2026 09:35AM
Aug 12, 2026 09:30AM
Jul 27, 2026 08:06AM Aptevo files patent for Nectin-4 x PD-L1 dual-targeting backbone
Jul 27, 2026 08:05AM
Jun 30, 2026 08:06AM
Jun 30, 2026 08:05AM
May 28, 2026 08:05AM
May 28, 2026 08:05AM
May 27, 2026 08:05AM
May 27, 2026 08:05AM Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
May 13, 2026 08:07AM
May 13, 2026 08:05AM
May 6, 2026 08:10AM
May 6, 2026 08:05AM
Mar 26, 2026 08:05AM
Mar 19, 2026 08:05AM
Mar 10, 2026 08:21AM Aptevo reports 86% clinical benefit rate for AML drug mipletamig
Mar 10, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 28, 2026 04:23PM
Jan 9, 2026 08:05AM
Jan 9, 2026 08:05AM
Dec 26, 2025 08:05AM Aptevo Therapeutics announces 1-for-18 reverse stock split
Dec 26, 2025 08:05AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 6, 2025 08:05AM
Oct 8, 2025 08:20AM Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter
Oct 1, 2025 04:34PM
Sep 16, 2025 08:34AM
Sep 16, 2025 08:30AM
Sep 5, 2025 09:00AM
Sep 4, 2025 08:46AM
Sep 4, 2025 08:45AM
Aug 13, 2025 08:06AM Aptevo highlights preclinical prostate cancer therapy candidate
Aug 13, 2025 08:05AM
Aug 11, 2025 10:53AM
Aug 11, 2025 08:05AM
Aug 8, 2025 09:00AM
Jul 25, 2025 04:18PM
Jun 20, 2025 11:30AM
Jun 20, 2025 11:30AM Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Jun 20, 2025 08:55AM

454,888 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All